Kevin Caldwell, Ossium’s Co-Founder & CEO, was featured on the latest podcast from Flux. Kevin chats with Flux’s Alice Lloyd George about Ossium’s mission, the history of bone marrow transplants, and the future of medicine.
Dr. Erik Woods has been inducted as a Fellow of the Society for Cryobiology and will be recognized at the 58th annual meeting of the Society taking place July 20-23rd in Chicago with the Luyet Medal for his extensive work in cryobiology.
Dr. Woods, a career stem cell and low-temperature biologist, is a prolific inventor, company founder, and researcher who has developed, refined, and patented methods for preserving cells and tissues and taken basic science through technology to the clinic in associated cGMP/GTP/GCP environments. He is one of 22 current distinguished Fellows of Society that are nominated by a special committee and elected by the Board of Governors on the basis of their research and continued service to the society.
The Society for Cryobiology established the award of Cryo-Fellow in 2005 to recognize members of the Society and individuals from the cryobiology community at large who have had an outstanding impact on the field. Newly elected fellows are presented with the prestigious Basile J. Luyet medal at the Society’s awards ceremony during the annual meeting.
The assessment criteria for Fellows are:
ABOUT SFC
|
The Society for Cryobiology was founded in 1964 to bring together those from the biological, medical and physical sciences who have a common interest in the effect of low temperatures on biological systems. The purpose of the Society is to promote scientific research in low-temperature biology, to improve scientific understanding in this field, and to disseminate and apply this knowledge to the benefit of mankind. The objectives of the Society are fulfilled in two primary ways. First, the Society organizes an annual scientific meeting dedicated to all aspects of low-temperature biology. This international meeting offers opportunities for presentation and discussion of the most up-to-date research in cryobiology as well as reviewing specific aspects through symposia and workshops. Second, the Society publishes a journal, Cryobiology, which is the foremost scientific publication in this area, with approximately 120 refereed contributions published each year. |
The National Institutes of Health notified Ossium that its proposal to demonstrate that the pool of viable, deceased donors for bone marrow transplants includes tissue donors — deceased donors who do not satisfy all of the health requirements of organ donors — is likely to be accepted. The NIH‘s decision to support Ossium’s research could eventually unlock substantial funding for a project that could dramatically expand the pool of viable deceased bone marrow donors, enabling thousands of additional patients to receive lifesaving stem cell transplants each year.
Leading venture capital firm First Round Capital — early investors in Uber, Square, Flatiron Health and more than 250 other companies — has backed Ossium Health. The San Francisco, New York, and Philadelphia based VC specializes in early stage companies, pairing its “seed investments” with a suite of company-building services for its portfolio companies.
Dr. Erik Woods — former President of the International Society for Cryobiology, Founder, President and CEO of General Biotechnology, and SVP & Lead Scientist of Cook Regentec — joined Ossium Health as Co-Founder and Chief Science Officer this month, rounding out Ossium’s founding team with deep scientific expertise.
Recent Comments